Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2026 Autoimmune Neurology Conference | Industry Therapeutic Update from Amgen: Management of gMG and NMOSD Patients with Clinical Evidence Informing Treatment Strategies and Patient Care

Saturday 08/08/26
12:15 PM - 01:15 PM CDT Add To Calendar
This program will be presented in-person only
This program is not expected to be available in the meeting's On Demand product.
Industry Therapeutic Update
General Neurology
Join us for a presentation on the management of gMG and NMOSD. This session will review the mechanistic rationale and clinical evidence informing treatment strategies and patient care.
No CME available
Event Timeline
No timeline events available at this time.
Faculty Disclosures
Adnan Subei, DO, FÂ鶹´«Ã½Ó³»­ Dr. Subei has received personal compensation for serving as an employee of Neurology Consultants of Dallas. Dr. Subei has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Subei has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Meyer Squibb. Dr. Subei has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Subei has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Subei has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Subei has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Subei has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. The institution of Dr. Subei has received research support from Novartis. The institution of Dr. Subei has received research support from Sanofi. The institution of Dr. Subei has received research support from Dianthus.